A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome

Kirstine Calloe; Jonathan M Cordeiro; José M Di Diego; Rie S Hansen; Morten Grunnet; Søren Peter Olesen; Charles Antzelevitch

doi:10.1093/cvr/cvn339

A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome

Kirstine Calloe, Jonathan M Cordeiro, José M Di Diego, Rie S Hansen, Morten Grunnet, Søren Peter Olesen, Charles Antzelevitch

Physiology of circulation, kidney and lung

83 Citations (Scopus)

Abstract

AIMS: Transient outward potassium current (I(to)) is thought to be central to the pathogenesis of the Brugada syndrome (BrS). However, an I((to)) activator has not been available with which to validate this hypothesis. Here, we provide a direct test of the hypothesis using a novel I(to) activator, NS5806. METHODS AND RESULTS: Isolated canine ventricular myocytes and coronary-perfused wedge preparations were used. Whole-cell patch-clamp studies showed that NS5806 (10 microM) increased peak I(to) at +40 mV by 79 +/- 4% (24.5 +/- 2.2 to 43.6 +/- 3.4 pA/pF, n = 7) and slowed the time constant of inactivation from 12.6 +/- 3.2 to 20.3 +/- 2.9 ms (n = 7). The total charge carried by I(to) increased by 186% (from 363.9 +/- 40.0 to 1042.0 +/- 103.5 pA x ms/pF, n = 7). In ventricular wedge preparations, NS5806 increased phase 1 and notch amplitude of the action potential in the epicardium, but not in the endocardium, and accentuated the ECG J-wave, leading to the development of phase 2 re-entry and polymorphic ventricular tachycardia (n = 9). Although sodium and calcium channel blockers are capable of inducing BrS only in right ventricular (RV) wedge preparations, the I(to) activator was able to induce the phenotype in wedges from both ventricles. NS5806 induced BrS in 4/6 right and 2/10 left ventricular wedge preparations. CONCLUSION: The I(to) activator NS5806 recapitulates the electrographic and arrhythmic manifestation of BrS, providing evidence in support of its pivotal role in the genesis of the disease. Our findings also suggest that a genetic defect leading to a gain of function of I(to) could explain variants of BrS, in which ST-segment elevation or J-waves are evident in both right and left ECG leads.

Original language	English
Journal	Cardiovascular Research
Volume	81
Issue number	4
Pages (from-to)	686-94
Number of pages	8
ISSN	0008-6363
DOIs	https://doi.org/10.1093/cvr/cvn339
Publication status	Published - 2008

Access to Document

10.1093/cvr/cvn339

Cite this

@article{a960a920f56111ddbf70000ea68e967b,

title = "A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome",

abstract = "AIMS: Transient outward potassium current (I(to)) is thought to be central to the pathogenesis of the Brugada syndrome (BrS). However, an I((to)) activator has not been available with which to validate this hypothesis. Here, we provide a direct test of the hypothesis using a novel I(to) activator, NS5806. METHODS AND RESULTS: Isolated canine ventricular myocytes and coronary-perfused wedge preparations were used. Whole-cell patch-clamp studies showed that NS5806 (10 microM) increased peak I(to) at +40 mV by 79 +/- 4% (24.5 +/- 2.2 to 43.6 +/- 3.4 pA/pF, n = 7) and slowed the time constant of inactivation from 12.6 +/- 3.2 to 20.3 +/- 2.9 ms (n = 7). The total charge carried by I(to) increased by 186% (from 363.9 +/- 40.0 to 1042.0 +/- 103.5 pA x ms/pF, n = 7). In ventricular wedge preparations, NS5806 increased phase 1 and notch amplitude of the action potential in the epicardium, but not in the endocardium, and accentuated the ECG J-wave, leading to the development of phase 2 re-entry and polymorphic ventricular tachycardia (n = 9). Although sodium and calcium channel blockers are capable of inducing BrS only in right ventricular (RV) wedge preparations, the I(to) activator was able to induce the phenotype in wedges from both ventricles. NS5806 induced BrS in 4/6 right and 2/10 left ventricular wedge preparations. CONCLUSION: The I(to) activator NS5806 recapitulates the electrographic and arrhythmic manifestation of BrS, providing evidence in support of its pivotal role in the genesis of the disease. Our findings also suggest that a genetic defect leading to a gain of function of I(to) could explain variants of BrS, in which ST-segment elevation or J-waves are evident in both right and left ECG leads.",

author = "Kirstine Calloe and Cordeiro, {Jonathan M} and {Di Diego}, {Jos{\'e} M} and Hansen, {Rie S} and Morten Grunnet and Olesen, {S{\o}ren Peter} and Charles Antzelevitch",

note = "Keywords: Action Potentials; Animals; Brugada Syndrome; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Endocardium; Heart Ventricles; Membrane Transport Modulators; Mutation; Myocytes, Cardiac; Pericardium; Phenylurea Compounds; Potassium; Potassium Channels; Tetrazoles; Time Factors",

year = "2008",

doi = "10.1093/cvr/cvn339",

language = "English",

volume = "81",

pages = "686--94",

journal = "Cardiovascular Research",

issn = "0008-6363",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome

AU - Calloe, Kirstine

AU - Cordeiro, Jonathan M

AU - Di Diego, José M

AU - Hansen, Rie S

AU - Grunnet, Morten

AU - Olesen, Søren Peter

AU - Antzelevitch, Charles

N1 - Keywords: Action Potentials; Animals; Brugada Syndrome; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Endocardium; Heart Ventricles; Membrane Transport Modulators; Mutation; Myocytes, Cardiac; Pericardium; Phenylurea Compounds; Potassium; Potassium Channels; Tetrazoles; Time Factors

PY - 2008

Y1 - 2008

N2 - AIMS: Transient outward potassium current (I(to)) is thought to be central to the pathogenesis of the Brugada syndrome (BrS). However, an I((to)) activator has not been available with which to validate this hypothesis. Here, we provide a direct test of the hypothesis using a novel I(to) activator, NS5806. METHODS AND RESULTS: Isolated canine ventricular myocytes and coronary-perfused wedge preparations were used. Whole-cell patch-clamp studies showed that NS5806 (10 microM) increased peak I(to) at +40 mV by 79 +/- 4% (24.5 +/- 2.2 to 43.6 +/- 3.4 pA/pF, n = 7) and slowed the time constant of inactivation from 12.6 +/- 3.2 to 20.3 +/- 2.9 ms (n = 7). The total charge carried by I(to) increased by 186% (from 363.9 +/- 40.0 to 1042.0 +/- 103.5 pA x ms/pF, n = 7). In ventricular wedge preparations, NS5806 increased phase 1 and notch amplitude of the action potential in the epicardium, but not in the endocardium, and accentuated the ECG J-wave, leading to the development of phase 2 re-entry and polymorphic ventricular tachycardia (n = 9). Although sodium and calcium channel blockers are capable of inducing BrS only in right ventricular (RV) wedge preparations, the I(to) activator was able to induce the phenotype in wedges from both ventricles. NS5806 induced BrS in 4/6 right and 2/10 left ventricular wedge preparations. CONCLUSION: The I(to) activator NS5806 recapitulates the electrographic and arrhythmic manifestation of BrS, providing evidence in support of its pivotal role in the genesis of the disease. Our findings also suggest that a genetic defect leading to a gain of function of I(to) could explain variants of BrS, in which ST-segment elevation or J-waves are evident in both right and left ECG leads.

AB - AIMS: Transient outward potassium current (I(to)) is thought to be central to the pathogenesis of the Brugada syndrome (BrS). However, an I((to)) activator has not been available with which to validate this hypothesis. Here, we provide a direct test of the hypothesis using a novel I(to) activator, NS5806. METHODS AND RESULTS: Isolated canine ventricular myocytes and coronary-perfused wedge preparations were used. Whole-cell patch-clamp studies showed that NS5806 (10 microM) increased peak I(to) at +40 mV by 79 +/- 4% (24.5 +/- 2.2 to 43.6 +/- 3.4 pA/pF, n = 7) and slowed the time constant of inactivation from 12.6 +/- 3.2 to 20.3 +/- 2.9 ms (n = 7). The total charge carried by I(to) increased by 186% (from 363.9 +/- 40.0 to 1042.0 +/- 103.5 pA x ms/pF, n = 7). In ventricular wedge preparations, NS5806 increased phase 1 and notch amplitude of the action potential in the epicardium, but not in the endocardium, and accentuated the ECG J-wave, leading to the development of phase 2 re-entry and polymorphic ventricular tachycardia (n = 9). Although sodium and calcium channel blockers are capable of inducing BrS only in right ventricular (RV) wedge preparations, the I(to) activator was able to induce the phenotype in wedges from both ventricles. NS5806 induced BrS in 4/6 right and 2/10 left ventricular wedge preparations. CONCLUSION: The I(to) activator NS5806 recapitulates the electrographic and arrhythmic manifestation of BrS, providing evidence in support of its pivotal role in the genesis of the disease. Our findings also suggest that a genetic defect leading to a gain of function of I(to) could explain variants of BrS, in which ST-segment elevation or J-waves are evident in both right and left ECG leads.

U2 - 10.1093/cvr/cvn339

DO - 10.1093/cvr/cvn339

M3 - Journal article

C2 - 19073629

SN - 0008-6363

VL - 81

SP - 686

EP - 694

JO - Cardiovascular Research

JF - Cardiovascular Research

IS - 4

ER -

A transient outward potassium current activator recapitulates the electrocardiographic manifestations of Brugada syndrome

Abstract

Access to Document

Fingerprint

Cite this